11 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
Glycemic #Diabetes #DM2 ... Medication #Algorithm #Endocrinology ... #PrimaryCare #Management
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #Management
Indications for Parathyroidectomy in Primary Hyperparathyroidism
 • All patients with symptomatic PHPT
 • Serum calcium 1
with symptomatic PHPT ... #Indications #PHPT ... #endocrinology ... #management #Hyperparathyroidism
Diabetes Medication Prescribing Algorithm

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured

#Diabetes #Medications #Prescribing #Algorithm #management
Prescribing #Algorithm #management ... #endocrinology ... #dm2
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Type 2 Medication Management ... CKD #Diabetes #DM2 ... Type2 #Medication #Management ... #Algorithm #endocrinology
Impact and Challenges With Vitamin D to Treat Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
Ergocalciferol (D2 ... Effectively suppresses SHPT ... - Suppresses SHPT ... - Suppresses SHPT ... CKD #Nephrology #Management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
table #comparison #management ... #endocrinology ... #dm2
Hyperglycemic Crisis - Algorithm for DKA/HHS

Diagnostic criteria for DKA:
 • pH < 7.3
 • Anion gap
Crisis #Algorithm #management ... #endocrinology ... #Diabetes #DM2 #
Management of Polycystic Ovary Syndrome (PCOS)
Hyperandrogenism, Family Planning, Endometrial cancer prevention, Cardiovascular risk factor management
→ Weight
Management of Polycystic ... Cardiovascular risk factor management ... Letrozole (BMI >30 kg/m2 ... Ovary #Syndrome #Management ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
#Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology